Navigation Links
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Date:10/3/2007

's history of operating losses since inception and its need for additional funds to operate its business; the costs, delays and uncertainties inherent in scientific research, drug development, clinical trials and the regulatory approval process; the risk that clinical trials for Genaera's product candidates, including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine may be delayed or may not be successful; the risk that Genaera may not obtain regulatory approval for its products, whether due to adequacy of the development program, the conduct of the clinical trials, changing regulatory requirements, different methods of evaluating and interpreting data, regulatory interpretations of clinical risk and benefit, or otherwise; Genaera's reliance on its collaborators, in connection with the development and commercialization of Genaera's product candidates; market acceptance of Genaera's products, if regulatory approval is achieved; competition; general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industry; and the other risks and uncertainties discussed in this announcement and in Genaera's filings with the U.S. Securities and Exchange Commission, all of which are available from the Commission in its EDGAR database at http://www.sec.gov as well as other sources. You are encouraged to read these reports. Given the uncertainties affecting development stage pharmaceutical companies, you are cautioned not to place undue reliance on any such forward-looking statements, any of which may turn out to be wrong due to inaccurate assumptions, unknown risks, uncertainties or other factors. Genaera does not intend (and it is not obligated) to publicly update, revise or correct these forward-looking statements or the risk factors that may relate thereto.


'/>"/>
SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genaera Discontinues Lomucin in Cystic Fibrosis Studies
2. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
3. PM announces a new health care order for India
4. Ramdoss Announces Introduction of RCH-II
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Tibet Announces the Dalai Lama’s Tour of South Americ
8. NHS announces further Cost cutting Measures
9. Indian PM Announces Of Setting Up India Study Center At Tashkent
10. PowderMed Announces Needle-Less Flu Vaccine
11. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Tampa, FL (PRWEB) December 19, 2014 ... Celliant Revitalizing Bedsheets are now available. Celliant, the ... in both sheets and pillowcases. , There are ... clinically proven additional circulation, increased oxygenation and balanced ... quality, faster healing and pain relief; enhanced athletic ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 SuperCloset raises ... SuperClone Rooms. SuperCloset continues to offer indoor growers the ... one of the new SuperClone Rooms with the award ... and turnkey indoor hydroponic grow room setup. , The ... world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... 20, 2014 An evening dress is perfect ... lady’s closet. Discount-Dress.com, a distinguished dresses retailer, has unveiled its ... dresses in this great shopping platform. Customers can ... staff's hard work, Discount-Dress.com has been accepted and praised by ... and easier shopping stage for clients. In order to expand ...
(Date:12/19/2014)... research warns parents that buying an older car for their teens ... teen drivers killed in the United States between 2008 and 2012 ... often lacked important safety features that are available on newer cars, ... crashes were in cars at least six years old, 34 percent ... in cars 11 to 15 years old, and 17 percent were ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Potentially illness-causing E. coli bacteria ... farmers markets, according to a new study. Researchers ... from 13 farmers markets in Los Angeles and Orange ... of almost 150 samples tested, 24 percent were positive ... according to the researchers. Both types of bacteria ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... researchers at the University of California, San Diego School of ... weight change is a key contributor to the success of ... The results were published today in the advanced online ... at things such as parenting skills and styles, or changing ...
... HealthDay Reporter , WEDNESDAY, March 14 (HealthDay News) -- ... intestinal illness known as gastroenteritis have more than doubled in ... one of two germs in particular -- C. difficile ... Researchers at the U.S. Centers for Disease Control and ...
... WEDNESDAY, March 14 (HealthDay News) -- A newly approved gel ... is a common precursor to squamous cell skin cancer, a ... even months to treat the condition, but the new product ... matter of days, according to the report in the March ...
... , WEDNESDAY, March 14 (HealthDay News) -- Living ... grocery stores and produce markets is good for your ... from more than 6,000 people who were assessed for ... physical activity, fasting blood sugar, blood pressure and smoking. ...
... (HealthDay News) -- The number of foodborne disease outbreaks ... in recent years, according to a new federal government ... Control and Prevention reviewed outbreaks reported to the CDC,s ... During those five years there were 39 outbreaks and ...
... Columbia University Medical Center (CUMC) scientists have developed ... a mouse. The "personalized immune mouse" offers researchers an ... to type 1 diabetes and other autoimmune diseases, starting ... today in the online edition of Science Translational ...
Cached Medicine News:Health News:How to best help your child lose weight: Lose weight yourself 2Health News:U.S. Deaths From Gastro Infections Doubled Over 8 Years: CDC 2Health News:U.S. Deaths From Gastro Infections Doubled Over 8 Years: CDC 3Health News:New Gel Treats Precancerous Skin Condition in Days: Study 2Health News:Your Neighborhood Can Affect Your Heart Health 2Health News:Recent Rise Seen in Foodborne Diseases From Imports: CDC 2Health News:'Personalized immune' mouse offers new tool for studying autoimmune diseases 2Health News:'Personalized immune' mouse offers new tool for studying autoimmune diseases 3
(Date:12/19/2014)... 19, 2014 TODAY, AEGATE, the ... World announced the appointment of Peter Fox ... Chief Channels and Partner Officer. Peter has ... to its acquisition by Oracle in 2011. ... Geneva and subsequently Convergys, a world ...
(Date:12/19/2014)... 2014  Advanced Medical Isotope Corporation ("AMIC") (OTCQB:  ... in the development of brachytherapy devices and medical ... that a Life Sciences Discovery Fund (LSDF) Proof ... AMIC is the commercialization partner.  The award was ... proposal titled "Optimized Injectable Radiogels for High-dose Therapy ...
(Date:12/19/2014)... Dec. 19, 2014 In today,s increasingly ... web presence to reflect the needs of a ... must meet the needs of key stakeholders while ... According to recent research by benchmarking ... the participating companies averaged more than $100,000 in ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Building a Best-in-Class Pharma Global Brand Website 2
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... of high-powered Xenon, Metal Halide and ... in a durable, lightweight design. In ... light guide cables, providing optimal brightness ... design., Extraordinarily compact yet offering light ...
... high-powered Xenon, Metal Halide and Halogen ... a durable, lightweight design. In addition, ... guide cables, providing optimal brightness in ... Powerful illumination and simple design - ...
... The Olympus Ultrasonic Lithotriptor LUS-2 combines ... improve both procedural performance and cost-efficiency. ... design that helps to minimize hand ... powerfully disintegrates calculi while simultaneously removing ...
Medicine Products: